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The problem. Two sibling brothers have been previously 
diagnosed as Bloom's Syndrome (BS). Due to Lack of 
demonstrable increased sister chromatid exchange (SCE) in 
their blood cells and fibroblasts, diagnosis of BS is in 
question. 
Procedure. This study examined the immune reactions of 
these siblings with such tests of immune function as: T- 
and 3-cells, T-cell subsets, ehemotaxis, nitroblue 
tetrazolium (NBT), mitogen stimulation and mixed lymphocyte 
culture (MLC) . 
Findings. Results are compared with those of other 
known 3s subjects. Analysis of our patients' immune systems 
seems to agree with findings of previous studies. 
Conclusion. While there is a correlation of 
immunolosical and clinical data, qenetically there are none 
of the eipected abnormalities,  his study has not ruled out 
the possibility of a misdiagnosis of BS. 
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INTRODUCTION 
Dr. David Bloom first noted a Bloom's Syndrome (BS) 
patient in 1341. The patient was described as a dwarf who 
presented an eruption on the face resembling Lupus 
erythematosis in addition to a bullous eruption on the lips 
due to hypersensitivity to sunlight (Bloom 1954). In 1953 
two more cases were presented to the New York Academy of 
Medicine. It was believed at the time that three such 
identical cases might constitute a syndrome. 
Dr. Bloom's original male patient, aged nine years, 
was born to Jewish parents and had a facial skin eruption 
from the age of two years. Born full term at four pounds 
the patient weighed only nine pounds at one year. At nine 
years he was the size of a small four year old with a narrow 
face giving the appearance of precocious senility. The 
areas of the face not affected by erythematous rash appear 
wrinkled, the rash assuming a butterfly shape. On the 
patient's trunk were numerous cafe au lait spots, The 
patient was treated with growth hormone from 1941-1943, In 
1948 he had grown eight and one-half inches and was a 
second-year high school student. 
German and Bloom (1977) were the first to associate 
the risk of cancer with Bloom's. A BS Registry had begun in 
1963 when the second of the three first cases died of acute 
leukemia. By 1976 there were 32 recognized as  loom's 
Syndrome and at the end of 1979 a total of 71 were 
registered. Only those persons presenting the cardinal 
features defined by Bloom in 1966 were accepted into the 
registry- These symptoms included congenital telangieetatic 
erythema of the face, sensitivity to sunlight and stunted 
growth (Bloom 1966). 
As early as 1963 it became clear that cellular 
chromatid interchange was a characteristic finding in BS. 
About 1974 it was discovered that the number of sister 
chromatid exchanges (SCE) in dividing BS lymphocytes were 
many times greater than in normal lymphocytes. The SGE 
phenomenon is now known to be a cancer-related condition 
(Siniscaleo 1977). 
In the patients followed by Bloom and German, 
leukemia was the type of cancer found in nearly half of the 
cases. Leukemias appeared at earlier ages than did solid 
tumors. Bloom and German felt that BS individuals may have 
the greatest predisposition to cancer of all the known I 
recessively transmitted disorders of man. 
Today we know that BS is a rare autosomal recessive 
disorder in which the affected individual is at increased 
risk of cancer. The major features of this syndrome are: 
growth deficiency (including prenatal growth retardation 
with low birth weight), short stature, characteristic sun- 
sensitive telangiectatic erythema of the face and other 
exposed areas of skin. Cultured BS fibroblasts have 
retarded DNA-replication fork displacement and there is a 
greatly increased frequency of SCE and an elevated 
spontaneous mutation rate (Lechner et al. 1983). 
The purpose of this project was to examine the immune 
response in two male sibl ings (ages seven and six years) 
diagnosed as having BS. Little literature has been 
published dealing with the immune function of such 
patients, Previous work suggests that both humoral and 
cellular immune responses are affected. There is a pattern 
of abnormal serum concentration of at least one class of 
immunoglobulins, an impaired response to pokeweed mitogen 
stimulation and a mixed lymphocyte culture (NLC) showing BS 
cells to be normal stimulators but poor responders. These 
defects in the immune system may result in multiple 
infections for the BS patient. These two patients have 
displayed frequent bouts of otitis media, upper respiratory 
infections and gastro-intestinal complications. 
METHODS AND PROCEDURES 
Blood in heparinized and ethylenediaminetetracetic 
acid (EDTA) tubes was drawn from the two BS patients and 
their parents along with a normal control. The blood for 
ehemotaxis and nitroblue tetrazolium (NBT) tests was 
separated. Remaining blood was prepared on a density 
gradient to isolate lymphocytes for use in T- and B-cell 
enumeration, T-cell subsets, mitogen stimulation and mixed 
lymphocyte culture. Reparinized blood was layered in 10 ml 
amounts on density gradient and spun in the centrifuge at 
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400 xg for 30 minutes. The layer of mononuclear lymphocytes 
was then harvested for testing. 
Chemotaxis 
One or two rnl of blood specimen in EDTA from 
patients, parents and control were incubated in appropriate 
vials of N-Formyl-L-methionyl-L-phenylalanine (F-met-phe) 
purchased from Sigma Chemical. Final dilutions were 50 and 
100 picamoles of F-met-phe. 
The samples were mixed and incubated in the vials at 
room temperature for 30 minutes. They were then remixed and 
monolayer films of blood prepared on glass slides. Slides 
were stained with Wright's stain and examined under a light 
microscope for the presence of bipolar-shaped neutrophils, 
One hundred neutrophils were counted on each slide and the 
percent of bipolar cells was recorded (Jadwin et al. 1981). 
NBT (Nitroblue tetrozolium test) 
Heparinized blood (1.5 ml) was placed in two test 
tubes. To one of the tubes 15 p 1  of endotoxin was added as 
a stimulant. All tubes were then incubated at 3 7 O ~  for 10 
minutes in a waterbath. NBT solution (0.3 ml at 0,15%) was 
added and blood was run through nylon wool columns, rinsed 
twice with phosphate buffered saline then once with 
distilled water to lyse the red blood cells. A few drops of 
0.1 M HC1 was placed in each column to stop the reaction. 
Then columns were rinsed again with 2 ml of distilled 
water. Extracted nylon wool was placed in test tubes 
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containing 5 ml of dioxane. Dioxane tubes were heated in a 
7Ooc water bath for 20 minutes with frequent shaking to 
extract the blue formazan product, Tubes were centrifuged 
to remove any nylon wool fibers. The optical densities of 
the solutions were then measured at 520 nm on a 
spectrophotometer, 
T- and B-cells 
For T- and B-cell assays, mononuclear cells were 
incubated with latex particles to mark the monocytes. 
T-cells were tested for by the E-rosette procedure, 
Cells (5 x lo5) were mixed with 0.1 ml of sheep red blood 
cells [SRBC) and incubated for 10 minutes at 37O~. SRBC 
were at a concentration of 25 ~1 of packed cells/5 ml 
d i l u e n t ,  The mixture was then centrifuged at 200 xg and 
incubated overnight at 4OC. The next morning 1 0  pf of 
trypan blue stain was added and the cells were mixed gently 
by Pasteur pipette and loaded into a hemocytometer for 
counting. Rosettes consisting of a lymphocyte with 3 or 
more attached SRBC were enumerated and percentages recorded. 
For B-cells, 200 ~1 of mononuclear cells at a 
concentration of 1 x 107/ml were mixed with FITC conjugated 
goat anti-human IgG F(ab)'2 (Cappel Laboratories), incubated 
at 4*C for 30-40 minutes then washed with a 20% solution of 
sodium azide three times. A drop of cell suspension was 
placed on a glass slide, covered with a coverslip and edges 
sealed with nail polish. B-cells were counted using the 
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fluorescent microscope and the percent of Ig positive cells 
were noted. 
T-cell Subsets 
T-cell subsets were detected using monoclonal 
antibodies. Cells (I x 10') were mixed with 10 p1 of 
reagent for the T-helper/suppressor ratio test 
(Becton/Bickinssnf and incubated for 30 minutes at ~ O C  in 
ice. T4 (helper) and T8 (suppressor) cells were counted 
simultaneously, the T4 fluorescing as orange and the TB as 
green. A total of 100 cells were counted and the results 
were recorded both in percent and ratio form. 
Mitoqen Studies 
Mononuclear cells were separated from heparinized 
whole blood using sterile technique. All tubes, solutions 
and pipette tips were sterile. The cells were diluted in 
stimulation medium consisting of: 0.5 ml pen/strep 
(penicillin 5000 units, streptomycin 5000 pg/rnl), 0.5 ml 
L-glutamine (200 mM) in 50 ml of RPMI 1640 culture medium. 
The final dilution was 2 x lo5 cells/ml. 
Mitogen dilutions for phytohemagglutin antigen (PHA) 
were: 0.125, 0.5, 1.0, 2.0, and 4.0 ~g/ml. Conclavalin A 
dilutions were: 2.5, 5.0 10.0, 20.0, and 40.0 ug/ml. 
Microtiter plates were prepared as follows: 
20 p1 control serum (pooled human AB) 
100 p1 leukocyte suspension 
80 ~1 mitogen dilutions 
All tests were done in triplicate. The solutions 
were mixed by a gentle tapping of the plates which were then 
incubated at 37OC in 5% C02 for 3 days. 
~adioactive 
thymidine (Mew England Nuclear) in 10 yl amounts (at a 
concentration of 1 uCi/lO p1) was added to each well and the 
plates were incubated a further 4 hours, Cells were 
harvested by Mash Cell Harvester on fiberglass filters. 
Filter punches were placed in scintillation vials, 3 ml of 
scintillation fluid added and radioactivity was counted on a 
Beckman beta counter. Stimulation indexes were calculated 
and reported in graph form. Stimulation indexes were 
determined by the formula: 
Mean counts/min for rnitoqen SI = Mean counts/min for control 
Pokeweed mitogen (provided by Drake University) was 
diluted as per instructions and used in 3 dilutions of 1/10, 
1/100, and 1/1000. The same techniques were employed as for 
the previous mitogen tests except the incubation period was 
5 days. 
Mixed Lymphocyte Culture (MLC) 
Separated lymphocytes were divided into two portions 
for patients, parents and control. One portion of cells was 
treated with rnitomycin C (Sigma Chemical) at 0.25 mg/ml and 
incubated for 20 minutes at 3 7 O ~  in 5% GO;?* The cells were 
then washed 3 times in culture medium and designated 
"stimulator cells." The final concentration of both cell 
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suspensions was 5 x lo5 cells/ml in culture medium with 20% 
pooled human serum ( P H s ) ,  
The test was set up in microtiter plates with all 
possible combinations of cells done in triplicate. 
Stimulator cells were placed in the platest vertical rows 
and responder cells were added to horizantaf rows. At the 
end of each row vertically and horizontally were blanks 
(designated PHs) consisting only of cells and medium. 
Set up of microtiter plates: 
(Stimulator cells) 
Father Mother Sibl Sib2 Control Blank 
Father ---- 
Mother 
Sibl 
Sib2 
Control 
Blank 
(Responder cells) 
The plates were mixed gently by tapping and incubated 
for six days at 3.7'~ in 5% C02. At the end of the 
incubation period thymidine (at the same concentration as in 
the mitogen stimulation) was added to all wells and plates 
were incubated an additional six hours. Plates were 
harvested as in the mitogen procedure above and counted in a 
beta counter. 
RESULTS 
Results of the chemotaxis studies are shown in Table 
1 as the Percent of neutrophils exhibiting bipolar 
configuration, Counted as bipolar were those cells with 
distinctly elongated shapes or with the presence of a 
uropod, indicating reactivity to the f-met peptide, None of 
the results varied greatly from that of the normal control 
though sibling 1 (Sib 1) seemed to have the least reaction 
ta chemotactic factor as compared to the others. 
The NBT results are noted in Table 2. A stimulation 
index for stimulated cells should be approximately 2-4 times 
that of non-stimulated cells. The father showed the lowest 
stimulation index at 1.1. With stimulation indexes of 2.5, 
2.8, and 3.0, respectively, the mother and siblings were 
well within normal ranges so we find basically normal 
phagocytic capabilities. 
T- and B-cells were mostly within normal ranges. As 
illustrated in Table 3 the absolute values for T- and B- 
cells for our subjects fall basically within the limits set 
by our laboratory according to a previous study based upon 
normal patients of various age groups. The only number out 
of the expected normals was that for the B-cell count of 
Sib 1. The absolute value of $4 was considerably below the 
normal range of 125-684. 
Table 1, Results of chemotaxis test reported in percent of 
bipolar neutrsphils observes. 
F-me t-phe Father Mother Sib 1 Sib 2 Control 
Table 2. The findings of the NBT assay recorded both as 
0. D. reading and stimulation index (calculated by 
dividing 0. D. reading of stimulated sample by 
0. D. reading of non-stimulated sample). 
0.  D. Father Mother Sib 1 Sib 2 Control 
Stim 0.075 0.125 0.070 0.030 0,025 
Non-S t im 0.0'70 0.050 0.025 0.010 0.010 
Stim Ix 1.1 2.5 2.8 3.0 2.5 
Table 3. T- and B - c e l l  eounts expressed as percentages and absolute 
value. A t ~ ~ l u t e  values are the Ikvmphocyte oomt x t he  percent 
of cells enumerated. Normals are based on tests performed spl 
n o m l  patients of the  same age group. 
'9, Absolute W m i s  % Absolute Normals 
E-rosettes Value for  age Wells Value for  age 
Father 59 % 1926 385-1723 5% 163 48-330 
Mother 80% 2464 385-1723 5% 154 48-330 
S i b  1 60.5% 1316 875-2628 2% 44 125-684 
S i b  2 46.5% 1281 875-2628 6% 165 125-684 
Control  68 % 885 385-1723 5% 65 48-330 
T a b l e  4 .  T-cell s u b s e t s  as e x p r e s s e d  i n  p e r c e n t  and T4/T8 
r a t io .  
S u b s e t  F a t h e r  Mother  S i b  1 S i b  2 C o n t r o l  
- 
T4/hef  per 77% 71% 81% 60% 78% 
T 8 / s u p p r e s s o r  23% 29 % 19% 40% 22% 
R a t i o  3 .35 2.24 4.26 1 .50  3 .55 
T-cell subsets seem to be normal also as noted in 
Table 4. The average T4/T8 ratio is 1.9 c 0.7. All the 
ratios for this test fall within these limits though sib 2 
is in the lower ranges of normal. 
The mitogen stimulation presents varied results. As 
seen in Figures 1 and 2, both parents and control have a 
good reaction to mitogens PHA and Con-A, though the father's 
response was not as marked as the mother's. Sibling 1 
responded only fairly to PHA and Con-A, while Sibling 2 had 
a moderate response to both mitogens, Figure 1 illustrates 
responses to PHA as expressed by the stimulation index, 
Figure 2 notes the stimulation indexes at the various 
concentrations of Con-A. 
The sibling B-cell response to Pokeweed mitogen was 
poor, One may note in looking at Figure 3 that the parents 
had excellent responses to the mitogen, even greater than 
that of the control, while those of the siblings were nearly 
flat at all three concentrations. 
In Table 5 counts per minute (cpm) for the mixed 
lymphocyte culture (MLC) are recorded. While several of the 
counts were obviously in error (possibly due to 
contamination or pipetting error), one can see a definite 
trend on the part of the two siblings to be poor 
responders. By looking at the stimulation indexes indicated 
in Table 6 one notes in the horizontal rows (responder 
cells) obvious lack of response by the cells of the BS 
(Sib 1) 
(Father) 
0.125 0.5 1.0 2.0 4 , O  
Concentration of PEA in micrograms/ml 
Figure 1. Stimulation indexes for the mitogen PHA. 
/- 
(Control) 
2.5 5.0 10 .O 20.0 40.0 
Concentration of Con-A in micrograms/ml 
Figure 2. Stimulation indexes for the mitogen Con-A. 
- (Control) 
1/10 1/100 l/loao 
Dilutions of Pokeweed Mitogen 
Figure 3. Stimulation indexes for Pokeweed Mitogen (PWM). 
Table 5. Covnts per minute of harvested cells i n  (W) , The (xf sows 
ind ica te  s t h u l a t o r  cells, while the horizontal  rows represent 
responder cells. Underlined nlrmbers are t he  base l i n e  counts 
used i n  f iguring st imulation indexes for Table 6. 
Father (x) Mother (x) S i b  1 (x) Sib 2 (x) Ccmtrol ( x )  PIES (x) 
Father - 397 1042 1086 I613 629 263 
Mother: 1269 - 331 369 867 2974 230 
S i b  1 227 242 - 265 376 1186 880 
S i b  2 28 7 220 207 - 346 607 1751 
Conitrol 691 188 6 59 498 - 227 230 
pH5 307 255 277 27 0 230 -- 
Table 6. Stimulation indexes i n  the MIX. 
Father (x) Mother (x) S i b  l (x) S i b  2 (x) Control (x) 
Father -- 3 3 4 2 
Mother 
Sib 1 1 1 - 2 7 
0 0 0 -- S i b  2 2 
3 0 3 2 -- Control  
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siblings. The stimulating capacity of the BS cells 
(vertical rows) do not differ significantly from that of the 
control lymphocytes. 
Due to the small number of tests performed it was 
impossible to statistically analyze the results of this 
study. Ideally more controls would have been included but 
due to the complicated nature of most of the tests and the 
availability of only one technician the study had to be 
designed as it was. As a case study these observations will 
hope£ ully prove to be of value. 
DISCUSSION 
Patients' Medical Aistory 
The medical history of these two BS siblings is 
complex, Sibling 1 was born July 14, 1977, with a birth 
weight of six pounds. He was diagnosed at age one as having 
BS. There were gastrointestinal complications. Failure to 
thrive was apparent at an early age. At 16 months growth 
hormones were normal but x-rays estimated a retarded bone 
age to be similar to that of a newborn. A quantitative 
immunoglobulin assay revealed that this sibling possessed 
abnormally low concentrations of both IgG and IgM 
antibody. The thyroid stimulating hormone (TSH) was low. 
Glucose, total protein and carotene concentrations were all 
low. Electrolyte levels were normal. A 24-hour urine amino 
acid analysis showed this patient to possess abnormally low 
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levels of nearly every amino acid assayed. The significance 
of this is not known. 
At 18 months a chromosome analysis at Mayo Clinic 
reported no apparent abnormalities. Sibling 1's medical 
history has a plethora of such observations as upper 
respiratory infection, otitis media and failure to thrive. 
Due to recurrent otitis media a myringotomy with tubes was 
performed. 
This sibling seems to be eapecialLy sun sensitive. 
Bouts with ezcernatous, erythernatous, irnpetiginous rashes 
were treated with hydrocortisone. At age six he was 
admitted to the hospital with entire body scaling (including 
the scalp), an oozing from flexural skin and fissures and 
crusting in those areas. 
Chromosome work was repeated at this time at the 
University of Iowa, There was no change in this sibling or 
in sibling 2 who had also been diagnosed as BS. No 
increased chromosomal breakage or increased sister chromatid 
exchange (SCE) weve noted, 
Sibling 2 was born July 22, 197er  weighing five 
pounds four ounces and having apgars of 7 and 7. Be had a 
history of vomiting and diarrhea with attendant 
hypokalernia. Again diagnosed as failure to thrive he was 
transferred to Mayo Clinic. A 24-hour urine amino acid 
assay revealed that this patient (like his sibling) to have 
low concentrations af most amino acids assayed. 
~mmunoglobulin levels revealed him to have low 
concentrations of IgG and IgA. 
At one year the characteristic butterfly facial rash 
was noted and a genetics consult for BS was suggested. At 
18 112 months sibling 2 was diagnosed as BS in spite of the 
fact that there was no increase in chromosomal breakage. He 
had a continuing history of gastrointestinal, respiratory 
and ear problems. 
A letter from the Iowa Department of Health dated 
September I979 states that these siblings have many features 
which fit the diagnosis of BS: Pre- and post-natal growth 
failure, mild microeneephaly (no dolichocephaly noted), 
malap rash with livedo reticu1ari.s. They noted sibling 1's 
extreme light sensitivity and stated that there was no 
malformation of the hands or feet. It was also observed 
that there was no Jewish ancestry--the mother being Dutch- 
Irish and the father English-Irish-German. The disease is 
most common in children of Jewish ancestry and seems to have 
been previously limited to those of Ashkenazim heritage 
(German et al. 1977). 
A physical exam at the Uni-~ersity of Iowa in April of 
1983 described both boys as short for their ages with 
erythenataus rash on their faces. Both were stated as 
having high palates and knock knees. Both were below the 
third percentile in height and weight. Neither sibling 
exhibited cafe au lait spots which is a COInmon feature in 
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many BS individuals. No hypogonadism was noted. 
On August 6, 1984, the parents received a letter from 
the Division of Medical Genetics at the University of 
Iowa. The letter stated that the geneticists did not 
believe these siblings have BS since they hadn't been able 
to demonstrate SCE's of increased frequency. They also felt 
that these children were not at increased risk for 
malignancy. 
According to the tests performed in this study the 
parents' and sibling's neutrophils appear to be operating 
normally and their chemotactic and phagocytic abilities seem 
to be within acceptable limits. The T- and B-cell 
populations also fall in normal ranges along with T-cell 
subsets. An abnormal response was observed with the mitogen 
stimulation of lymphocytes. Sibling 1 showed a somewhat 
impaired response to both PHA and Con-A while sibling 2 had 
a better response to both mitogens. According to both 
Weemaes et al, (1979) and Hutteroth et al. (19751, BS 
individuals show a lower response to PHA than normal 
controls, though in Weemaes' study of two families one 
family did have normal response to PHA which leads one to 
think that this trait may be variable. 
Pokeweed mitogen response was poor in both 
siblings. Previous studies (Weemaes et al. 1979; ~utteroth 
et al. 1975) indicate this response would be expected.   he 
reason for lack of response may lie with the T4 (helper) and 
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T8 (sup~ressor) T-cell subsets. Suppressor cells bearing 
receptors for IgG may suppress B-cell differentiation 
promoted by PWM (Schoen 19673, Helper cells bear IgM 
receptors that "preactivateu £3-cells so that PWM can 
transform them into plasma cells. In the presence of PtJM 
the suppressor cells release soluble factors that suppress 
B-cell proliferation. This suggests that suppressor cells 
can suppress induction of polyclonal B-cell differentiation 
by acting indirectly on helper cells. 
Studies by Taniguehi et al. fl982) suggest that 
peripheral blood lymphocytes in BS patients are defective in 
both 3-eel1 ability to produce immunoglobulins and in T-cell 
help for 3-cell differentiation, as if functional maturation 
of the lymphocytes were arrested at an early stage of immune 
ontology. 
Due to the lack of B-cell stirnufation by pm one 
might correctly assume that BS subjects will be deficient in 
one or more classes of immunoglobulins. This fact is born 
out by both of the siblings in this study. Such a 
deficiency in BS may prove important in helping to explain 
the clinical picture and pathogenesis of this disease. The 
low gamma globulin levels may even be a factor in the 
development of leukemia. Children with agammaglobulinernia 
are known to develop acute lymphatic leukemia (Page et al. 
1963). 
While hypogonadism is not found in these two siblings 
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it is a clinical finding in many BS subjects. Shabtai and 
Nalbreeht (1980) describe a BS patient in which there was 
increased chromosomal breakage and SCE. They found this man 
to be infertile at age 33 due to hypogonadism. Fifteen 
percent of this patient" cells were missing the Y 
chromosome. According to Padre-Mendoza et al, (1979) a 
missing Y has been implicated in the development of 
hematologic malignancies, especially in young people. 
Results of the mixed lymphocyte culture in this study 
concur with results one would expect to find in a BS 
patient. The siblings were obviously poor responders but 
average stimulators. The ability of lymphocytes from 
persons with BS to react with allogenic cells in this test 
was also observed in previous works (Weemaes et al. 1979; 
Hutteroth et al. 1975). Past studies demonstrated, as did 
ours, that BS lymphocytes responded less vigorously to 
normal stimulator lymphocytes thad did normal responder 
lymphocytes to normal stimulator lymphocytes. There seems 
to be both decreased T-cell function (decreased responder 
activity in MLC) and 8-cell abnormalities (shown in 
decreased serum concentration of at least one immunoglobulin 
class) in BS. 
Hutteroth et al. (1975) suggest that immunological 
abnormalities in BS may be secondary to a disturbance in 
cellular proliferation. They believe that this disturbance 
could cause a specific pattern of immune defects the 
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severity of which would depend on the nature of the defect 
and the class of cells affected. Miller and Todaro (1969) 
speculate that a defective immune response in BS may play an 
important role in the incidence of malignancy. 
There is no direct evidence as yet correlating SCE 
and immune disf unction, but increased SCE is a cardinal 
feature in the BS patient, If the SCE'S involve any of the 
imunoglobulin genes, then obviously immune function would 
be effected. This type of exchange has not been documented. 
Santesson et al, (1969) stated that SCE levels in 
normal B-cells were significantly lower than those in the T- 
cells of the same individuals. Others observed (Lindblad 
and Lambert 1981; German et al. 1977) that a population of 
PHA stimulated lymphocytes exhibited a normal level of SCE 
in some BS individuals. These results were thought to be 
indicative of a dimorphism which could be ascribed to the 
low SCE values that they found in BS B-cells as compared to 
normal B-cells, 
Block et al. (1982) experimented with SCE levels in 
T- and B-cells from five BS patients. They stimulated 8- 
cells with mi togens specific for them such as liposacchar ide 
and Epstein-Barr virus. Their results demonstrated SCE 
levels in B-cells of BS patients to be very high and similar 
to those of T-cells. They concluded that there was no 
dimorphism in regard to SCE in the lymphocyte population of 
the BS cases studied. 
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Sckmberg and German (1980) suggest that elevated 
SCE's in persons with BS are a molecular defect related to 
DNA metabolism. While other studies (Selsky et al. 1979; 
Thompson and Wolliday 1983) have shown that the DNA regair 
mechanisms are intact in the BS patient, Schoenberg and 
German state that the various chromosome abnormalities in BS 
may result from an excessive accumulation of lesions in the 
DNA on which a repair system must act thereby overloading 
the system. They felt that such lesions might result from 
the action of a genetically defective enzyme leading to the 
production of a molecule with mutagenic properties. 
Barnabei and Kelly (1982) suggest that BS fibroblasts 
synthesize a metabolite capable of increasing SCE frequency 
in normal fibroblasts. The nature of such a factor remains 
unknown. Also of interest is the fact that when BS cells 
are grown in medium preconditioned by normal cells a 
reduction of SCEts is noted. Schmidt-Preu et a l .  (1981) 
speculate that this "corrective factor" from normal cells 
may be a gene product which is defective or absent in BS 
cells. 
Warren et al. (1981) thought it conceivable that when 
the bl gene is homozygous it may have mutator activity. 
Their experiment demonstrated that fibroblasts from BS had a 
5- to 10-fold increase in spontaneous mutations over control 
fibroblasts. They concluded that when the gene bl is 
homozygous it may have significant mutator activity 

CONCLUSIONS 
There appear to be many theories as to the etiology 
of BS. At present most of the observations are speculation 
based on clinical and laboratory data. The clinical picture 
of the siblings in this study is noted in Table 7 and is 
compared to other known cases of BS. 
The results of this immunological study seem to 
correlate with those of previous studies. As expected from 
past work with BS our patients had normal T- and B-cell 
numbers and T-cell subsets. Though there was no literature 
concerning chemotaxis and NBT findings both siblings and 
parents demonstrated normal abilities. While the mitogen 
reactions were varied, the results of the MLC and pokeweed 
stimulation gave classic BS responses. 
Bloom's Syndrome is difficult to diagnose. 
Intrauterine and postnatal growth retardation is a 
Consistent feature. Skin lesions may vary considerably. 
Such minor abnormalities such as body asymmetry and cline 
(micro) dactyly might suggest a diagnosis of Silver-Russell 
Syndrome in some patients. BS must also be differentiated 
from other types of dwarfism and skin abnormalities like 
Rothmund-Thompson Syndrome and Cockayne's Syndrome 
(Vanderschueren-Lodewycky et al. 3.984). 
Decreased immunoglobulin levels are characteristic of 
B S ,  but may vary as seen in our two siblings. While no 
direct relationship has as yet been established between 
Table 7. Symptoms found in diagnosed BS individuals as 
compared to the symptoms noted in the two siblings 
of this study. 
Symptoms of BS: Present Absent 
Growth retardation (pre- & post-natal) x 
Sun sensitivity x 
Erythematous rash 
Increased SCE 
Abnormal immunoglobulin levels 
Microcephaly 
Doliochocephaly 
Cafe au lait spots 
Wypogonad ism 
Impaired response PWM 
Poor responder MLC 
X 
x (mild) 
X 
X 
X 
Increased infections X 
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immunoglobulin deficiency and the chronic infections which 
seem to plague the BS patient, it can't help but be a factor 
as evidenced by repeated infections in our study's siblings. 
The very high rate of S C E k  is now considered an 
essential feature of BS. This makes it difficult to give a 
definite diagnosis of BS in the subjects of this study. 
While they have many of the classic symptoms of BS one 
critical factor is absent, an increased number of SCE's. 
The results of this study do agree, fo r  the most 
part, with those found in other BS studies' but similar 
results may also be found in other genetically defective 
syndromes. There are definite abnormalities in the immune 
systems of these siblings and they do fit the basic clinical 
description of the typical BS patient. Do these boys have 
BS? The answer is still equivocal. 
In future years possibly a chromosome instability 
will manifest itself but without the demonstration of 
increased SCE's one must agree that, at least genetically, 
these siblings' risk of cancer is not increased at this 
time. The chronic infections these patients f ace  are not 
life threatening and have generally been controlled with 
proper treatment. 
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